Viewing Study NCT04332367


Ignite Creation Date: 2025-12-25 @ 12:35 AM
Ignite Modification Date: 2025-12-25 @ 10:44 PM
Study NCT ID: NCT04332367
Status: RECRUITING
Last Update Posted: 2025-06-06
First Post: 2020-03-11
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
Sponsor:
Organization: